{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T17:49:43Z","timestamp":1759513783790},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2002,3,1]]},"DOI":"10.1038\/sj.pcan.4500555","type":"journal-article","created":{"date-parts":[[2004,6,14]],"date-time":"2004-06-14T13:34:25Z","timestamp":1087220065000},"page":"32-35","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prostate cancer screening at an equal access tertiary care center: its impact 10 years after the introduction of PSA"],"prefix":"10.1038","volume":"5","author":[{"given":"D W","family":"Soderdahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,3,11]]},"reference":[{"key":"BF4500555_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","volume":"50","author":"RT Greenlee","year":"2000","unstructured":"Greenlee RT, Murray T, Bolden S, Wingo P. . Cancer statistics, 2000. Cancer J Clin 2000 50: 7\u201333.","journal-title":"Cancer J Clin"},{"key":"BF4500555_CR2","first-page":"31","volume":"17","author":"DW Keetch","year":"1996","unstructured":"Keetch DW, Andriole GL. . Prostate cancer screening: what are physicians to do? What have we learned? Monographs in Urology 1996 17: 31\u201348.","journal-title":"Monographs in Urology"},{"key":"BF4500555_CR3","first-page":"19","volume":"2","author":"JC Presti","year":"2000","unstructured":"Presti JC, Schr\u00f6eder FH, Albert PS, Lynch J. . Early diagnosis and staging of prostate cancer. 10th International Prostate Cancer Update. Rev Urol 2000 2: 19\u201322.","journal-title":"Rev Urol"},{"key":"BF4500555_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/jnci\/91.12.1033","volume":"91","author":"R Etzioni","year":"1999","unstructured":"Etzioni R et al. Cancer surveillance series: interpreting trends in prostate cancer--part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst 1999 91: 1033\u20131039.","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"BF4500555_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1464-410X.1997.tb00804.x","volume":"79","author":"FH Schr\u00f6der","year":"1997","unstructured":"Schr\u00f6der FH, Bangma CH. . The European randomized study of screening for prostate cancer. Br J Urol 1997 79: Suppl 1 68\u201371.","journal-title":"Br J Urol"},{"key":"BF4500555_CR6","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/cncr.2820690521","volume":"69","author":"RJ Babaian","year":"1992","unstructured":"Babaian RJ et al. The relationship of prostate specific antigen to digital rectal examination and transrectal ultrasonography. Cancer 1992 69: 1195\u20131200.","journal-title":"Cancer"},{"key":"BF4500555_CR7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/00007611-199407000-00009","volume":"87","author":"PR Bretton","year":"1994","unstructured":"Bretton PR. . Prostate specific antigen and digital rectal examination in screening for prostate cancer. Southern Med J 1994 87: 720\u2013723.","journal-title":"Southern Med J"},{"key":"BF4500555_CR8","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","volume":"151","author":"WJ Catalona","year":"1994","unstructured":"Catalona WJ et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer. J Urol 1994 151: 1283\u20131290.","journal-title":"J Urol"},{"key":"BF4500555_CR9","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0022-5347(01)61630-6","volume":"161","author":"JB Rietbergen","year":"1999","unstructured":"Rietbergen JB et al. The changing pattern of prostate cancer at the time of diagnosis. J Urol 1999 161: 1192\u20131198.","journal-title":"J Urol"},{"key":"BF4500555_CR10","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0022-5347(17)37401-3","volume":"147","author":"MK Brawer","year":"1992","unstructured":"Brawer MK et al. Screening for prostatic carcinoma with prostate specific antigen. J Urol 1992 147: 841\u2013845.","journal-title":"J Urol"},{"key":"BF4500555_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0022-5347(01)65322-9","volume":"157","author":"LA Eskew","year":"1997","unstructured":"Eskew LA, Bare RL, McCullough DL. . Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997 157: 199\u2013202.","journal-title":"J Urol"},{"key":"BF4500555_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1001\/jama.1993.03510070082041","volume":"270","author":"JE Oesterling","year":"1993","unstructured":"Oesterling JE et al. Serum prostate specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993 270: 860\u2013865.","journal-title":"JAMA"},{"key":"BF4500555_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0002-9343(98)00113-2","volume":"104","author":"JB Meigs","year":"1998","unstructured":"Meigs JB et al. High rates of prostate specific antigen testing in men with evidence of benign prostatic hyperplasia. Am J Med 1998 104: 517\u2013525.","journal-title":"Am J Med"},{"key":"BF4500555_CR14","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1001\/jama.1997.03540420052029","volume":"277","author":"HB Carter","year":"1997","unstructured":"Carter HB et al. Recommended prostate specific antigen testing intervals for the detection of curable prostate cancer. JAMA 1997 277: 1456\u20131460.","journal-title":"JAMA"},{"key":"BF4500555_CR15","first-page":"117","volume":"8","author":"PH Gann","year":"1997","unstructured":"Gann PH. . Interpreting recent trends in prostate cancer incidence and mortality. Epidemiology 1997 8: 117\u2013120.","journal-title":"Epidemiology"},{"issue":"Suppl 11","key":"BF4500555_CR16","first-page":"141","volume":"9","author":"IM Thompson","year":"1995","unstructured":"Thompson IM, Optenberg SA. . An overview cost-utility analysis of prostate cancer screening. Oncology (Huntingt) 1995 9: Suppl 11 141\u2013145.","journal-title":"Oncology (Huntingt)"},{"key":"BF4500555_CR17","doi-asserted-by":"publisher","first-page":"178.","DOI":"10.1016\/S0022-5347(01)64049-7","volume":"159","author":"JD Pearson","year":"1998","unstructured":"Pearson JD et al. When is PSA testing no longer necessary? J Urol 1998 159: 178.","journal-title":"J Urol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4500555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500555","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:25:23Z","timestamp":1648679123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4500555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,3,1]]}},"alternative-id":["BF4500555"],"URL":"https:\/\/doi.org\/10.1038\/sj.pcan.4500555","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3,1]]},"assertion":[{"value":"12 June 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2001","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2001","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2002","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}